Sox2OT was found to be crucial for the development and maintenance of the pluripotency of cancer stem cells (CSCs) [110], while its dysregulation was reported in several cancers including osteosarcoma, glioblastoma, lung and breast cancer, and others, where it plays an oncogenic or tumor-suppressor role [111]. The gene discussed is SOX2-OT; the disease is cancer.